A Novel 3D Visualization Method in Mice Identifies the Periportal Lamellar Complex (PLC) as a Key Regulator of Hepatic Ductal and Neuronal Branching Morphogenesis

This study introduces a novel high-resolution 3D imaging platform combining metallic compound nanoparticle perfusion and Liver-CUBIC tissue clearing to identify the Periportal Lamellar Complex (PLC) as a previously unrecognized, low-permeability endothelial structure that serves as a critical scaffold guiding bile duct and neuronal branching morphogenesis during liver fibrosis.

The Gist

The Big Picture: Seeing the Liver in 3D

Imagine the liver as a bustling, high-tech city. It has roads for blood (arteries and veins), pipes for waste removal (bile ducts), and a communication network (nerves). For a long time, scientists could only look at this city through a flat, 2D map (like a slice of bread). They knew the roads existed, but they couldn't see how they twisted, turned, and connected in the third dimension.

This paper introduces a new way to "lift the roof off" the liver city and see the whole 3D layout at once. The researchers built a special camera system and a new way to make the liver tissue transparent, allowing them to map the entire city down to the single-cell level.

The New Tools: The "Magic Ink" and the "Clearing Solution"

To see inside this dense city, the researchers had to solve two problems: the liver is naturally dark and cloudy, and the different systems (blood, bile, nerves) look the same color.

1. The "Clearing Solution" (Liver-CUBIC): Think of the liver like a sponge soaked in dark ink. The researchers developed a special chemical bath (a mix of urea and hydrogen peroxide) that acts like a magical eraser. It washes away the dark ink (pigments) and makes the sponge perfectly clear and transparent. Best of all, they sped this process up from 9 days to just 3 days.
2. The "Magic Ink" (Metal Nanoparticles): Once the liver is clear, they needed to color-code the different systems. Instead of regular dye, they used tiny metal nanoparticles that glow in different colors (Pink, Green, Yellow, Black).
   • Pink: Portal Veins (the main blood supply).
   • Green: Bile Ducts (the waste pipes).
   • Yellow: Hepatic Arteries (oxygen-rich blood).
   • Black: Central Veins (where blood leaves).

By injecting these "magic inks" into different parts of the liver, they could see the entire 3D network glowing in the dark, revealing how everything connects.

The Big Discovery: The "Periportal Lamellar Complex" (PLC)

Using this new 3D map, the researchers found something nobody had ever seen before. They discovered a new structure wrapped around the main blood vessels, which they named the Periportal Lamellar Complex (PLC).

The Analogy: The "Train Station Platform"
Imagine the main blood vessel (Portal Vein) as a giant train track running through the city.

• Before: Scientists thought the tracks just branched off into smaller lines.
• Now: They found a special "platform" or "waiting area" (the PLC) built right around the main track. This platform isn't just empty space; it's a complex, layered structure that acts as a gateway.

This gateway has three superpowers:

1. The Gatekeeper: It controls what gets through. It's like a security checkpoint that is very hard to penetrate, keeping the main blood flow separate from the surrounding tissue.
2. The Construction Site: It's where the "construction crews" (stem cells) hang out. The cells in this area have special markers (CD34 and Sca-1) that tell us they are like "master builders" capable of turning into different types of cells.
3. The Traffic Director: It guides the construction of new roads and pipes.

What Happens When the City Gets Sick? (Liver Fibrosis)

The researchers tested what happens when the liver gets injured (simulated by a chemical called CCl₄, which causes scarring or "fibrosis").

• The Expansion: In a healthy liver, the "platform" (PLC) is small and neat. But when the liver gets sick, the PLC stretches out like a growing vine, reaching deep into the city's neighborhoods.
• The Blueprint: As the PLC stretches, it acts as a guide rail. The bile ducts (waste pipes) and the nerves (communication lines) follow this stretched PLC, growing deeper into the tissue to try and repair the damage.
• The Connection: The study found that the "master builder" cells in the PLC are talking to the nerves and the pipes, telling them where to grow. It's like the PLC is the architect drawing the blueprints for the liver's repair crew.

Why Does This Matter?

This discovery changes how we understand the liver:

• It's not just a bag of cells: It's a highly organized 3D city with specific "hubs" (the PLC) that control how everything connects.
• New Hope for Cures: Since the PLC is the place where repair happens, and it contains special stem-like cells, doctors might be able to target this area to treat liver diseases like cirrhosis or even liver cancer. Instead of trying to fix the whole city, they might just need to fix the "platform."

Summary

The researchers built a super-clear, 3D map of the mouse liver. They found a hidden structure called the PLC that wraps around blood vessels. This structure acts as a control center that guides the growth of bile ducts and nerves, especially when the liver is trying to heal itself from injury. It's a fundamental discovery that could lead to better treatments for liver disease.

Technical Summary

1. Problem Statement

The liver possesses a highly complex, three-dimensional architecture involving intertwined vascular (portal vein, hepatic artery, central vein), biliary (bile ducts), and neuronal networks. Understanding the spatial relationships and functional interactions of these systems is critical for elucidating liver physiology, development, and disease mechanisms (e.g., fibrosis). However, current imaging technologies face significant limitations:

• 2D Histology: Provides high resolution but fails to reconstruct the true 3D continuity of ductal and vascular structures.
• Macroscopic Imaging (MRI, Micro-CT, Ultrasound): Offers whole-organ views but lacks the subcellular resolution required to visualize micrometer-scale vascular details and terminal interactions.
• Existing 3D Clearing Methods: Conventional tissue clearing protocols (e.g., CLARITY, standard CUBIC) struggle with the liver due to high heme content, lipofuscin, and dense cellular architecture, leading to poor optical transparency, light scattering, and long processing times (up to 9 days). Furthermore, existing methods lack efficient strategies for simultaneous, high-resolution, multi-target labeling of multiple ductal systems.

2. Methodology

The authors developed a comprehensive, high-fidelity 3D visualization platform tailored for the hepatic multi-ductal system, integrating three key innovations:

A. Optimized Tissue Clearing (Liver-CUBIC)

• Hybrid Protocol: The authors modified the standard CUBIC protocol by integrating a hydrogen peroxide (H₂O₂) bleaching step to remove heme and lipofuscin pigments.
• Reagent Optimization: Urea concentration was increased from 25% to 40% to enhance protein denaturation and refractive index homogenization.
• Performance: This "Liver-CUBIC" protocol reduced clearing time by 63.89% (from 9 days to 3.25 days) and increased optical transmittance in 1-mm-thick slices by 20.12% compared to conventional methods, without inducing significant tissue expansion.

B. Multicolor Metal Compound Nanoparticles (MCNPs)

• Labeling Strategy: Four distinct MCNP colors (Pink, Green, Black, Yellow) were used to perfuse and label specific systems simultaneously:
  • Yellow: Hepatic Artery (via left ventricle).
  • Green: Bile Ducts (retrograde via extrahepatic duct).
  • Pink: Portal Vein (direct injection).
  • Black: Central Vein (via inferior vena cava).
• Advantages: MCNPs offer high brightness, tunable multicolor properties, and strong resistance to H₂O₂ bleaching, enabling stable, simultaneous labeling of all major ductal systems at subcellular resolution.

C. Advanced Imaging and Analysis

• Imaging: Utilized Extended Depth-of-Field (EDOF) microscopy, confocal laser scanning microscopy (CLSM), and 3D DAB/TSA multiplex immunofluorescence.
• Transcriptomics: Re-analyzed public single-cell RNA sequencing (scRNA-seq) datasets of liver endothelial cells to identify molecular signatures of newly discovered structures.
• Disease Model: A CCl₄-induced mouse liver fibrosis model was established to observe structural remodeling during disease progression.

3. Key Contributions

• Technical Platform: Established a robust, high-throughput 3D imaging pipeline (Liver-CUBIC + MCNPs) capable of mapping the liver's ductal-vascular-neuronal network at single-cell resolution.
• Discovery of the PLC: Identified and defined a previously unrecognized structure, the Periportal Lamellar Complex (PLC), located in the adventitial layer of the portal vein.
• Molecular Characterization: Defined the PLC's unique cellular composition, specifically a CD34⁺Sca-1⁺ endothelial cell population with stem cell and hematopoietic niche potential.
• Functional Insight: Demonstrated that the PLC acts as a structural scaffold and regulatory hub for bile duct and nerve branching, particularly during liver fibrosis.

4. Key Results

A. Structural Organization of the Liver

• High-resolution 3D imaging revealed that terminal bile ducts form a 3D plexus with helical configurations, while portal veins exhibit a dense, radial micro-branching pattern in marginal areas, challenging the strict hierarchical bifurcation model.
• Central veins were found to possess sparse, circular fenestrae (5–10 μm) facilitating metabolite return and immune cell trafficking.

B. The Periportal Lamellar Complex (PLC)

• Morphology: The PLC consists of fine vascular branches radiating from the portal vein adventitia, forming a low-permeability barrier between the portal vein endothelium and the perisinusoidal region.
• Distribution: PLC structures are periodically distributed along the portal vein axis. Their area correlates positively with portal vein diameter, suggesting a functional adaptation to shear stress and blood flow regulation.
• Barrier Function: MCNP perfusion experiments showed that nanoparticles delivered via the portal vein are largely retained within the PLC core, indicating low permeability, whereas arterial dyes extend further into the periphery.

C. Spatial Juxtaposition with Bile Ducts

• The terminal bile ducts (Canals of Hering) are spatially colocalized with the PLC.
• Under high-pressure perfusion, dye leakage from bile ducts occurred specifically adjacent to PLC structures, not in the perisinusoidal regions, confirming the PLC as the anatomical interface for bile collection.
• Multiplex staining revealed that cholangiocytes extend along the PLC but often remain in an immature state without forming complete lumens, suggesting the PLC guides ductal morphogenesis.

D. Molecular Signature: CD34⁺Sca-1⁺ Endothelium

• scRNA-seq analysis identified a unique endothelial subpopulation within the PLC expressing CD34 and Sca-1 (Ly6a).
• Gene Expression: These cells upregulate genes associated with hematopoietic stem cells (e.g., Mecom, PDGFRα) and stem cell maintenance, suggesting the PLC functions as a local hematopoietic niche.
• Neurovascular Niche: The CD34⁺Sca-1⁺ population also expresses neurodevelopmental genes (e.g., Nrg1, Adgrg6, Ednrb). Sympathetic nerve fibers (TH⁺) form a "beads-on-a-string" network along the PLC, indicating the PLC regulates hepatic autonomic innervation.

E. Role in Liver Fibrosis

• In CCl₄-induced fibrosis, the PLC undergoes morphological expansion and elongation toward the hepatic lobule.
• The CD34⁺Sca-1⁺ endothelial population increases significantly.
• Bile ducts and sympathetic nerves progressively extend along the expanding PLC scaffold into the parenchyma, correlating with fibrosis severity. This suggests the PLC provides a structural and molecular scaffold for ductular reactions and neural remodeling during injury.

5. Significance

• Paradigm Shift: The discovery of the PLC challenges the traditional view of the liver's vascular architecture, introducing a new structural unit that bridges the portal vein, bile ducts, and nerves.
• Mechanistic Insight: The study elucidates the mechanism of ductal and neuronal branching morphogenesis, identifying the PLC as a critical "directional scaffold" and a microenvironment rich in stem/progenitor-like endothelial cells.
• Therapeutic Potential: The PLC and its CD34⁺Sca-1⁺ endothelial population represent novel therapeutic targets for liver diseases involving ductular reactions, such as cholangiocarcinoma, primary sclerosing cholangitis, and liver fibrosis.
• Methodological Advance: The Liver-CUBIC + MCNP platform sets a new standard for 3D organ imaging, overcoming previous barriers in resolution, depth, and multi-target labeling, and can be applied to study other complex organ systems.